Literature DB >> 19474289

Expression of angiogenesis-related genes in the cellular component of the blood of preeclamptic women.

Yuditiya Purwosunu1, Akihiko Sekizawa, Shiho Yoshimura, Antonio Farina, Noroyono Wibowo, Masamitsu Nakamura, Hanako Shimizu, Takashi Okai.   

Abstract

The purpose of this study is to assess the changes in the expression of angiogenesis-related genes in the cellular component of the blood from preeclamptic patients. Blood samples were obtained from the preeclampsia (PE) and control participants. Cellular RNA was analyzed by reverse transcription polymerase chain reaction (PCR) to identify any angiogenesis-related genes and thereby assess the mRNA expression among women with PE and controls during weeks 35 to 41 of gestation. Significant differences were observed between PE and controls in all of the angiogenesis-related genes examined. In PE, for the increased expression of transforming growth factor-beta1 (TGF-beta1), endoglin and fms-like tyrosine kinase-1 (Flt-1); and the reduced expression of vascular endothelial growth factor (VEGF), placental growth factor (PlGF). fms-Like tyrosine kinase-1 and endoglin significantly correlated with the systolic pressure, while VEGF, Flt-1, and endoglin all correlated with proteinuria. An altered expression of angiogenesis-related genes was demonstrated in the cellular component of blood from preeclamptic patients. These findings indicate that this approach may offer an alternative way for evaluating the pathogenesis of PE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19474289     DOI: 10.1177/1933719109336622

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  12 in total

1.  Maternal peripheral blood gene expression in early pregnancy and preeclampsia.

Authors:  Daniel A Enquobahrie; Chunfang Qiu; Seid Y Muhie; Michelle A Williams
Journal:  Int J Mol Epidemiol Genet       Date:  2010-12-29

2.  Midgestation maternal serum 25-hydroxyvitamin D level and soluble fms-like tyrosine kinase 1/placental growth factor ratio as predictors of severe preeclampsia.

Authors:  Padmashree Chaudhury Woodham; Julia E Brittain; Arthur M Baker; D Leann Long; Sina Haeri; Carlos A Camargo; Kim A Boggess; Alison M Stuebe
Journal:  Hypertension       Date:  2011-10-10       Impact factor: 10.190

Review 3.  A systematic review of endoglin gene expression in preeclampsia.

Authors:  Mandy J Bell; Yvette P Conley
Journal:  Biol Res Nurs       Date:  2011-09-15       Impact factor: 2.522

4.  Variation in endoglin pathway genes is associated with preeclampsia: a case-control candidate gene association study.

Authors:  Mandy J Bell; James M Roberts; Sandra A Founds; Arun Jeyabalan; Lauren Terhorst; Yvette P Conley
Journal:  BMC Pregnancy Childbirth       Date:  2013-04-01       Impact factor: 3.007

5.  Maternal omega-3 fatty acids and vitamin E improve placental angiogenesis in late-onset but not early-onset preeclampsia.

Authors:  Vaishali Kasture; Deepali Sundrani; Surabhi Dalvi; Mayur Swamy; Anvita Kale; Sadhana Joshi
Journal:  Mol Cell Biochem       Date:  2019-08-16       Impact factor: 3.842

6.  Accuracy of Soluble Endoglin for Diagnosis of Preeclampsia and its Severity

Authors:  Pooneh Nikuei; Minoo Rajaei; Kianoosh Malekzadeh; Azim Nejatizadeh; Fatemeh Mohseni; Ali AtashAbParvar
Journal:  Iran Biomed J       Date:  2017-05-31

7.  Expression of placental growth factor mRNA in preeclampsia.

Authors:  Pooneh Nikuei; Minoo Rajaei; Kianoosh Malekzadeh; Azim Nejatizadeh; Fatemeh Mohseni; Fatemeh Poordarvishi; Nasrin Ghashghaeezadeh; Mehrdad Mohtarami
Journal:  Int J Reprod Biomed       Date:  2017-03

8.  Expression levels of seven candidate genes in human peripheral blood mononuclear cells and their association with preeclampsia.

Authors:  M L Martinez-Fierro; I Garza-Veloz; K Carrillo-Sanchez; V Martinez-Gaytan; R Cortes-Flores; M A Ochoa-Torres; G G Guerrero; I P Rodriguez-Sanchez; C O Cancela-Murrieta; M Zamudio-Osuna; J I Badillo-Almaraz; C Castruita-De la Rosa
Journal:  Hypertens Pregnancy       Date:  2013-12-02       Impact factor: 2.108

9.  Endoglin pathway genetic variation in preeclampsia: A validation study in Norwegian and Latina cohorts.

Authors:  Mandy J Schmella; James M Roberts; Yvette P Conley; Dianxu Ren; Gro L Storvold; Sue A Ingles; Melissa L Wilson; Anne Catherine Staff; Carl A Hubel
Journal:  Pregnancy Hypertens       Date:  2017-11-15       Impact factor: 2.899

10.  Enhanced HIF2α expression during human trophoblast differentiation into syncytiotrophoblast suppresses transcription of placental growth factor.

Authors:  Tatsuya Fujii; Takeshi Nagamatsu; Kazuki Morita; Danny J Schust; Takayuki Iriyama; Atsushi Komatsu; Yutaka Osuga; Tomoyuki Fujii
Journal:  Sci Rep       Date:  2017-09-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.